The Food and Drug Administration (FDA) recently announced new guidelines that will affect the availability of compounded GLP-1 medications often used for weight loss
According to clinical trials, prescription GLP-1 medications typically lead to 518% weight loss, while studies of high-dose tirzepatide combined with intensive lifestyle support have reported reductions of up to ~25%
In iGlarLixi (insulin glargine: LIXI = 1:1) study, adult Japanese patients with T2DM lost more weight compared to the iGlar (insulin glargine U100) study (-0.51 kg vs
17 Drug History Table Date Format/Order and Outcome Completeness Validates that each entered prior/current therapy row has a drug name, start date and end date in yyyy/mmm format, and that end date is not earlier than start date (or is blank only if clearly indicated as ongoing per business rules)
50mg sodium per serving, fast-absorbing natural sugars, and ginger to keep your gut quiet when the effort gets hard